KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 77 filers reported holding KYMERA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,194,200 | -39.4% | 301,741 | +0.2% | 0.00% | -50.0% |
| Q2 2023 | $6,922,335 | -21.7% | 301,102 | +0.9% | 0.00% | -33.3% |
| Q1 2023 | $8,844,466 | +18.9% | 298,497 | +0.2% | 0.00% | +50.0% |
| Q4 2022 | $7,435,784 | +22.6% | 297,908 | +6.9% | 0.00% | 0.0% |
| Q3 2022 | $6,065,000 | +20.1% | 278,560 | +8.6% | 0.00% | 0.0% |
| Q2 2022 | $5,052,000 | -53.2% | 256,542 | +0.5% | 0.00% | -33.3% |
| Q1 2022 | $10,804,000 | -31.5% | 255,277 | +2.7% | 0.00% | -40.0% |
| Q4 2021 | $15,780,000 | +10.4% | 248,534 | +2.2% | 0.01% | 0.0% |
| Q3 2021 | $14,288,000 | +183.0% | 243,225 | +133.7% | 0.01% | +150.0% |
| Q2 2021 | $5,048,000 | +108.0% | 104,076 | +66.7% | 0.00% | +100.0% |
| Q1 2021 | $2,427,000 | -36.2% | 62,448 | +1.8% | 0.00% | -50.0% |
| Q4 2020 | $3,803,000 | – | 61,334 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 457,059 | $9,950,000 | 17.03% |
| Atlas Venture Life Science Advisors, LLC | 6,875,698 | $149,684,000 | 16.52% |
| BVF INC/IL | 4,692,604 | $102,158,000 | 4.22% |
| Aquilo Capital Management, LLC | 330,246 | $7,189,000 | 2.59% |
| Redmile Group, LLC | 2,876,637 | $62,624,000 | 2.43% |
| Artal Group S.A. | 1,500,000 | $32,655,000 | 1.39% |
| Deer Management Co. LLC | 615,895 | $13,408,000 | 0.94% |
| Avoro Capital Advisors LLC | 2,169,230 | $47,224,000 | 0.87% |
| AtonRa Partners | 34,462 | $750,000 | 0.74% |
| Rock Springs Capital Management LP | 1,046,743 | $22,788,000 | 0.59% |